Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Is CT-guided percutaneous radiofrequency ablation oncologically effective in patients with renal cell carcinoma?

Nature Clinical Practice Urology volume 5, pages 18–19 (2008)Cite this article

boxed-textZagoria RJ et al. (2007) Oncologic efficacy of CT-guided percutaneous radiofrequency ablation of renal cell carcinomas. AJR Am J Roentgenol 189: 429–436

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Frank I et al. (2005) Independent validation of the 2002 American Joint Committee on cancer primary tumor classification for renal cell carcinoma using a large, single institution cohort. J Urol 173: 1889–1892

    Article  Google Scholar 

  2. Chawla SN et al. (2006) The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. J Urol 175: 425–431

    Article  Google Scholar 

  3. Crispen PL et al.: Delayed intervention of small sporadic renal masses undergoing active surveillance. Cancer, in press

  4. Kunkle DA et al.: Excise, ablate or observe: the small renal mass dilemma. J Urol, in press

  5. Weight CJ et al. (2007) MRI is inadequate for monitoring renal tumor destruction following radiofrequency abloation [abstract #497]. J Urol 177

Download references

Acknowledgements

The synopsis was written by Rachel Murphy, Associate Editor, Nature Clinical Practice.

Author information

Author notes

  1. Fox Chase Cancer Center, Temple University School of Medicine, 333 Cottman Avenue, Philadelphia, PA 19111, USA robert.uzzo@fccc.edu

Authors and Affiliations

  1. RG Uzzo is Associate Professor in Urology and Director of Research, Urologic Oncology, at the Fox Chase Cancer Center, Temple University, Philadelphia, PA, USA.,

    Robert G Uzzo

Authors
  1. Robert G Uzzo
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Uzzo, R. Is CT-guided percutaneous radiofrequency ablation oncologically effective in patients with renal cell carcinoma?. Nat Rev Urol 5, 18–19 (2008). https://doi.org/10.1038/ncpuro0975

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpuro0975

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing